Alpha Tau Medical

DRTS · NASDAQ

$13.16+$0.26 (+2.02%)TodayMarket closed · Oct 23, 7:50 PM ET

Prev close $12.90

About DRTS

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.

Employees: 121
Headquarters: JERUSALEM
Listed: Mar 8, 2022
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: alphatau.com

Leadership

Alpha Tau Medical executives
Name	Title	Since	Age
Uzi Sofer	—	2015	51
Raphi Levy	—	—	37
Amnon Gat	—	—	47
Ronen Segal	—	—	50
Prof. Yona Keisari	—	—	75
Robert Den	—	—	43
Prof. Itzhak Kelson	—	—	82
Ruth Alon	—	—	70
David Milch	—	—	64
Maya Netser	—	—	—
Alan Adler	—	—	81
Michael Avruch	—	—	52
S. Blumenfeld	—	—	84
Gary Leibler	—	—	56
Peter Melnyk	—	—	60

Similar companies

Companies in the same industry as Alpha Tau Medical

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.